JUL 20, 2017 08:00 AM PDT

WEBINAR: Application of targeted next-generation sequencing (NGS) panels in neurodevelopmental disorder research

Speakers
  • Associated Professor, Department of Woman and Child Health, University of Padova, Italy
    Biography
      Dr. Alessandra Murgia is a Director of Laboratory of Molecular Genetics and Associate Professor of Pediatrics at Department of Neurosciences and Department of Woman's and Child's Health at University of Padua. She is a member of the American Society of Human Genetics, European Society of Human Genetics, and Italian Society of Human Genetics. Dr. Murgia's areas of interest include neurodevelopmental disorders, Intellectual Disability/Autism Spectrum Disorders, Early Onset Epilepsy, and Hereditary Deafness.
    • Senior Product Manager, Clinical Sequencing Division, Thermo Fisher Scientific
      Biography
        Francisco Hernandez-Guzman is a Senior Product Manager for the Clinical Sequencing Division at Thermo Fisher Scientific. He manages the Ion AmpliSeq Custom product line, which includes oversight of the automated custom design creation process in Ion AmpliSeq Designer, custom design services and overall order intake. Francisco received his PhD degree in Biophysics from State University of New York at Buffalo where he worked on projects involving structural biology studies of membrane proteins involved in the estrogen biosynthesis pathway, as well as antibody studies for therapies targeting melanoma. He received his MBA in Marketing from The Rady School of Management at the University of California, San Diego with a focus on marketing and new product development. Francisco has been working in the Life Sciences field for 20 years, has experience in both software field support and software product management. He has been a product manager for the past 7 years, and in the past 2 years he has been responsible for the full Ion AmpliSeq custom product line.

      Abstract:

      DATE: July 20, 2017
      TIME: 8:00am PT, 11:00am ET, 5:00pm CEST

      Neurodevelopmental disorders (NDDs) are clinically and etiologically highly heterogeneous and are characterized by a wide range of overlapping clinical features. These characteristics pose serious difficulties for diagnoses based on exclusive clinical criteria.  Etiological background of these disorders is essential in gaining fundamental insights into the pathogenic mechanisms and pave the way to a fine understanding of different phenotypes and variable clinical expression associated with NDDs. 

      The advancement of targeted next-generation sequencing (NGS) has been instrumental in accelerating the pace of discovery in the field of NDD research and testing. Targeted NGS helps researchers to analyze only the genes of their interest in a rapid, cost-effective manner and thus has the potential to transform the strategies and workflow of research on NDDs.  However, designing a custom panel for disease research requires hours of up-front work involving literature search to select the genes most appropriate for their research, often without any information about how the panel will perform in their lab. 

      In this webinar, Dr. Alessandra Murgia will discuss how her lab implemented targeted NGS to NDD research in a translational research lab. They will present their hands-on experience in utilizing Ion AmpliSeq On-Demand Panels, a custom panel solution that allows researchers to customize panels from a catalog of wet lab-verified genes most relevant in inherited disease research, simply by browsing based on disease research type. 

      Ion AmpliSeq Designer enables researchers to configure NGS panels from a growing catalog of pre-tested genes most relevant in inherited disease research. The new content search engine feature allows for an easy selection of genes by their degree of association as informed by widely accepted public databases such as MeSH.  Francisco Hernandez-Guzman, a Senior Product Manager from Thermo Fisher Scientific will demonstrate how to use this web-based primer design tool to customize a panel for Ion Torrent next generation sequencing.

      For Research Use Only. Not for use in diagnostic procedures. 

      Learning Objectives:

      • Learn about the utility of custom targeted gene panels in clinical research specifically in neurodevelopmental disorders research
      • Watch a live demonstration of designing a custom gene panel from a database of pre-tested genes relevant in inherited disease research


       


      Show Resources
      You May Also Like
      SEP 05, 2019 04:00 PM CEST
      C.E. CREDITS
      SEP 05, 2019 04:00 PM CEST
      DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
      JUN 05, 2019 05:00 PM CEST
      C.E. CREDITS
      JUN 05, 2019 05:00 PM CEST
      DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
      OCT 02, 2019 11:00 AM PDT
      OCT 02, 2019 11:00 AM PDT
      DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
      NOV 18, 2019 07:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      NOV 18, 2019 07:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
      AUG 13, 2019 09:00 AM PDT
      C.E. CREDITS
      AUG 13, 2019 09:00 AM PDT
      DATE: August 13, 2019TIME: 9:00am PT, 12:00pm ET, 5:00pm BST Molecular complexes are major constituents of cells, hence unraveling their mechanisms is key to fuller comprehension of c...
      AUG 27, 2019 09:00 AM PDT
      C.E. CREDITS
      AUG 27, 2019 09:00 AM PDT
      DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
      Loading Comments...
      Show Resources